PURPOSE: The 12-item WHO-DAS II was developed to assess the activity limitations and participation restrictions experienced by individuals irrespective of medical diagnosis. In this paper we examine the known-groups' validity of the instrument by evaluating its ability to discriminate between patients with/without major depression, patients with depression with/without medical comorbidity, and patients with depression with different depression severity. METHOD: The participants were 3,615 PC patients from 17 regions of Spain, with a first-time diagnosis of major depressive episode according to the general practitioner. The 12-item WHO-DAS II, the PHQ-9, and a chronic medical conditions checklist were administered during the consultation. RESULTS: The statistical analyses indicated that the 12-item WHO-DAS II was able to discriminate between patients with/without depression and between those with different depression severity. The ROC analysis revealed that with a cutoff score >or=50, the instrument correctly classified 70.4% of the sample (area under the ROC curve = .76; sensitivity = 71.4%; specificity = 67.6%). CONCLUSIONS: Overall, our results support the discriminant validity of the 12-item WHO-DAS II for major depression, being quite recommendable its use in epidemiological research.
PURPOSE: The 12-item WHO-DAS II was developed to assess the activity limitations and participation restrictions experienced by individuals irrespective of medical diagnosis. In this paper we examine the known-groups' validity of the instrument by evaluating its ability to discriminate between patients with/without major depression, patients with depression with/without medical comorbidity, and patients with depression with different depression severity. METHOD: The participants were 3,615 PC patients from 17 regions of Spain, with a first-time diagnosis of major depressive episode according to the general practitioner. The 12-item WHO-DAS II, the PHQ-9, and a chronic medical conditions checklist were administered during the consultation. RESULTS: The statistical analyses indicated that the 12-item WHO-DAS II was able to discriminate between patients with/without depression and between those with different depression severity. The ROC analysis revealed that with a cutoff score >or=50, the instrument correctly classified 70.4% of the sample (area under the ROC curve = .76; sensitivity = 71.4%; specificity = 67.6%). CONCLUSIONS: Overall, our results support the discriminant validity of the 12-item WHO-DAS II for major depression, being quite recommendable its use in epidemiological research.
Authors: Johan Ormel; Maria Petukhova; Somnath Chatterji; Sergio Aguilar-Gaxiola; Jordi Alonso; Matthias C Angermeyer; Evelyn J Bromet; Huibert Burger; Koen Demyttenaere; Giovanni de Girolamo; Josep Maria Haro; Irving Hwang; Elie Karam; Norito Kawakami; Jean Pierre Lépine; María Elena Medina-Mora; José Posada-Villa; Nancy Sampson; Kate Scott; T Bedirhan Ustün; Michael Von Korff; David R Williams; Mingyuan Zhang; Ronald C Kessler Journal: Br J Psychiatry Date: 2008-05 Impact factor: 9.319
Authors: Monica Cepoiu; Jane McCusker; Martin G Cole; Maida Sewitch; Eric Belzile; Antonio Ciampi Journal: J Gen Intern Med Date: 2007-10-26 Impact factor: 5.128
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: Amy M Kilbourne; David E Goodrich; Kristina M Nord; Celeste Van Poppelen; Julia Kyle; Mark S Bauer; Jeanette A Waxmonsky; Zongshan Lai; Hyungjin M Kim; Daniel Eisenberg; Marshall R Thomas Journal: Adm Policy Ment Health Date: 2015-09
Authors: Carlos G Forero; Elena Olariu; Pilar Álvarez; José-Ignacio Castro-Rodriguez; Maria Jesús Blasco; Gemma Vilagut; Víctor Pérez; Jordi Alonso Journal: Qual Life Res Date: 2018-04-10 Impact factor: 4.147
Authors: Paulo Ruiz-Grosso; Christian Loret de Mola; Johann M Vega-Dienstmaier; Jorge M Arevalo; Kristhy Chavez; Ana Vilela; Maria Lazo; Julio Huapaya Journal: PLoS One Date: 2012-10-08 Impact factor: 3.240
Authors: Maria Rubio-Valera; Imma Beneitez; María Teresa Peñarrubia-María; Juan V Luciano; Juan M Mendive; Paul McCrone; Martin Knapp; Ramon Sabés-Figuera; Katarzyna Kocyan; Javier García-Campayo; Antoni Serrano-Blanco Journal: BMC Psychiatry Date: 2015-03-31 Impact factor: 3.630
Authors: Laura González-Suñer; Cristina Carbonell-Duacastella; Ignacio Aznar-Lou; Maria Rubio-Valera; Maria Iglesias-González; Maria Teresa Peñarrubia-María; Montserrat Gil-Girbau; Antoni Serrano-Blanco Journal: Int J Environ Res Public Health Date: 2021-01-20 Impact factor: 3.390